Skip to main content

Immunotherapeutic agents: Their role in cellular immunity and their therapeutic potential

Springer Seminars in Immunopathology volume 8, pages 327–346 (1985)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Bekesi JG, Robey JP, Zimmerman E (1976) Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy or interferon. Cancer Res 36: 361

    Google Scholar 

  2. Ben-Efraim S (1977) Methanol extraction residue: Effects and mechanisms of action. Pharmacol Ther 1: 383

    Google Scholar 

  3. Carswell EA, Old LJ, Kassel L (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666

    PubMed  Google Scholar 

  4. Chedid L, Audibert F, LeFrancier P, Choay J, Lederer E (1976) Modulation of the immune response by a synthetic adjuvant and analogs. Proc Natl Acad Sci USA 73: 2472

    PubMed  Google Scholar 

  5. Chihara G, Maeda YY, Hamuro J, Sasaki T, Fukuoka F (1969) Inhibition of mouse sarcoma 180 by the polysaccharide fromLentinus erodes. Nature 222: 687

    PubMed  Google Scholar 

  6. Chirigos MA (ed) (1978) Immune modulation and control of neoplasia by adjuvant therapy. Progress in cancer research and therapy, Vol 7. Raven Press, New York

    Google Scholar 

  7. Chirigos MA, Pearson JW (1973) Cure of murine leukemia with drugs and interferon. JNCI 51:1367

    PubMed  Google Scholar 

  8. Cohen BE, Cohen IK (1973) Vitamin A: Adjuvant and steroid antagonist in the immune response. J Immunol 111: 1376

    PubMed  Google Scholar 

  9. Cohen MH, Chretien PB, Ihde DC, Fossieck BE, Makuch R, Bunn PA, Johnston AV, Shackney SE, Matthews MJ, Lipson SD, Kenady DE, Minna JD (1979) Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small cell lung cancer. DAMA 241: 1813

    Google Scholar 

  10. DiLuzio NR, McNamee R, Jones E, Lassoff S, Sear W, Hoffman EO (1976) Inhibition of growth and dissemination of Shay myelogenous leukemic tumor in rats and glucan-activated macrophages. Reticuloendothelial system in health and disease. Adv Exp Med Biol 73B: 397

    Google Scholar 

  11. Dumonde DC, Wolstencroft RA, Panagi GS, Mathew M, Morley J, Howson WT (1969) Lymphokines: Monoantibody mediators of cellular immunity generated by lymphocyte activation. Nature 224: 38

    PubMed  Google Scholar 

  12. Ellouz F, Adam A, Ciorbaru R, Lederer E (1974) Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun 59: 1317

    PubMed  Google Scholar 

  13. Fefer A, Goldstein AL (eds) (1982) The potential role of T cells in cancer therapy. Progress in cancer research and therapy, Vol 22. Raven Press, New York

    Google Scholar 

  14. Fenichel R, Chirigos MA (eds) (1985) Immune modulating agents and their mechanisms. Vol. 25. Marcel Dekker, New York

    Google Scholar 

  15. Goldstein AL, Chirigos MA (eds) (1981) Lymphokines and thymic hormones. Their potential utilization in cancer therapeutics. Progress in cancer research and therapy, Vol 20. Raven Press, New York

    Google Scholar 

  16. Halper B (1975)Corynebacterium parvum: Applications in experimental and clinical oncology. Plenum Press, New York

    Google Scholar 

  17. Halpern BN, Biozzi G, Stiffel C, Mouton D (1959) Effect de la stimulation du systems reticuloendothelial par l'inoculation du Bacille de Calmette-Guéin sur le development de l'epithelioma atypique T-8 de Guérin chez le rat. Seances Biol (Paris) 153: 919

    Google Scholar 

  18. Hersh E, Chirogos MA, Mastrangelo (eds) (1981) Augmenting agents in cancer therapy. Progress in cancer research and therapy, Vol 16. Raven Press, New York

    Google Scholar 

  19. Lotan R, Dennert G (1976) Stimulating effects of vitamin A analogs on induction of cell-mediated cytotoxicity in vivo. Cancer Res. 39: 55

    Google Scholar 

  20. Low TLK, Goldstein AL (1982) Maturation factors and cancer. In: Moore MAS (ed) Progress in cancer research and therapy, Vol 23. Raven Press, New York

    Google Scholar 

  21. Mathé G, Halle-Pannenko O, Bourut C (1974) Immune manipulation by BCG administered before or after cyclophosphamide for chemoimmunotherapy of L1210 leukemia. Eur J Cancer 10: 661

    PubMed  Google Scholar 

  22. Micksche M, Kokron O, Uchida A (1982) Clinical and immunopharmacological studies with OK432, a streptococcal preparation. In: Serrou B, Rosenfeld C (eds) Current concepts in Human immunology and cancer immunodulation. Elsevier Biomedical Press, BV, Amsterdam

    Google Scholar 

  23. Mihich E (ed) (1982) Immunological approaches to cancer therapeutics. John Wiley and Sons, New York

    Google Scholar 

  24. Mulè JJ, Shu S, Schwarz SL, Rosenberg SA (1984) Adoptive immunotherapy of established metastases with LAK cells and recombinant interleukin 2. Science 225: 1487

    PubMed  Google Scholar 

  25. Oehler JR, Herberman RB, Holden HT (1978) Modulation of immunity by macrophages. Pharmacol Ther 2: 551

    Google Scholar 

  26. Okamoto H, Shoin S, Kashimura S (1978) Streptomycin S-forming and anti-tumor activities of groupA. streptococci. In: Jeljaszewicz J, Waldström T (eds) Bacterial toxins and cell membranes. Academic Press, London, p. 259

    Google Scholar 

  27. Old IJ, Clarke DA, Benacerref B (1959) Effect of bacillus Calmette-Guérin infection on transplantable tumors in the mouse. Nature 184: 291

    PubMed  Google Scholar 

  28. Oppenheim JJ, Gerry I (1982) Interleukin-1 is more than an interleukin. Immunology Today 3: 113

    Google Scholar 

  29. Pierce CW, Aune TM (1981) Structure and mechanism of action of the lymphokine, soluble immune response suppressor. In: Goldstein AL, Chirogos MA (eds) Progress in cancer research and therapy, Vol 20. Raven Press, New York, p 195

    Google Scholar 

  30. Ribi EE, Meyer TJ, Azuma I (1973) Mycobacterial cell wall components in tumor suppression and regression. Mycrobacterial cell wall components in tumor suppression and regression. Natl Cancer Inst Monogr 39: 115

    PubMed  Google Scholar 

  31. Terry WD, Rosenberg SA (eds) (1982) Immunotherapy of human cancer. Excerpta Medica, Elsevier Science Publishers, Amsterdam

    Google Scholar 

  32. Waksman BH (1978) Modulation of immunity by soluble mediators. Pharmacol Ther 2: 623

    Google Scholar 

Download references

Author information

Affiliations

  1. Biological Therapeutic Branch, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, NIH, Frederick Cancer Research Facility, Building 560 Room 31-76, 21701, Frederick, MD

    Michael A. Chirigos

  2. Preclinical Screening Laboratory, Program Resources, Inc., NCI-Frederick Cancer Research Facility, Building 539 Room 220B, 21701, Frederick, MD, USA

    James E. Talmadge

Authors
  1. Michael A. Chirigos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James E. Talmadge
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The contents of this publication do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chirigos, M.A., Talmadge, J.E. Immunotherapeutic agents: Their role in cellular immunity and their therapeutic potential. Springer Semin Immunopathol 8, 327–346 (1985). https://doi.org/10.1007/BF01857388

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857388

Keywords

  • Internal Medicine
  • Therapeutic Potential
  • Cellular Immunity
  • Immunotherapeutic Agent